Efficacy of subcutaneous preemptive rituximab in immune-mediated thrombotic thrombocytopenic purpura: Experience from the first 12 cases

被引:7
|
作者
Delrue, Maxime [1 ,2 ]
Baylatry, Minh Tam [3 ]
Joly, Anne-Christine [3 ]
Corre, Elise [4 ,5 ]
Marjanovic, Zora [4 ]
El-Khoury-Hanna, Noujoud [6 ]
Feger, Frederic [7 ]
Suner, Ludovic [7 ,8 ]
Veyradier, Agnes [1 ,2 ,5 ]
Stepanian, Alain [1 ,2 ,5 ]
Coppo, Paul [4 ,5 ,9 ]
机构
[1] Univ Paris, Hop Lariboisiere, AP HP Nord, Serv Hematol Biol, Paris, France
[2] Inst Rech St Louis, Paris, France
[3] Sorbonne Univ, Hop St Antoine, AP HP, Pharm, Paris, France
[4] Sorbonne Univ, Hop St Antoine, AP HP, Serv Hematol, Paris, France
[5] Ctr Reference Microangiopathies Thrombot, Paris, France
[6] Ctr Hosp Reg Orleans, Serv Nephrol, Orleans, France
[7] Sorbonne Univ, Hop St Antoine, AP HP, Serv Hematol Biol, Paris, France
[8] Sorbonne Univ, INSERM, Ctr Rech St Antoine, CRSA, Paris, France
[9] Ctr Rech Cordeliers, INSERM UMRS 1138, Paris, France
关键词
D O I
10.1002/ajh.26022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E26 / E29
页数:5
相关论文
共 50 条
  • [22] Relapse Prediction Model for Immune-Mediated Thrombotic Thrombocytopenic Purpura
    Masias, Camila
    Yang, Shangbin
    Sukumar, Senthil
    Flowers, Alcinda
    Wu, Haiwa
    Carter, Krista
    Lin, Shili
    Han, Chenggon
    Cataland, Spero
    BLOOD, 2020, 136
  • [23] Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura
    Pascual-Izquierdo, Cristina
    del Rio-Garma, Julio
    de la Rubia, Javier
    Viejo, Aurora
    Mingot, Eva
    Cid, Joan
    Solanich, Xavier
    Fernandez-Sojo, Jesus
    Martin-Sanchez, Jesus
    Hernandez, Luis
    Maria Garcia-Gala, Jose
    Alonso, Nieves
    Gonzalez, Victoria
    Oliva, Ana
    Gomez-Segui, Ines
    Goterris, Rosa
    Guerra, Luisa
    Garcia-Candel, Faustino
    Fernandez-Docampo, Marta
    Luisa Antelo, Maria
    Salgado-Barreira, Angel
    Salinas, Ramon
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (04) : 563 - 573
  • [24] The efficacy of reuse therapeutic plasma exchange in relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a single-center experience of 130 cases
    Mastanzade, M. Guzel
    Besisik, S. Kalayoglu
    Dadin, S. Altay
    Aktan, M.
    Hindilerden, I. Yonal
    Yenerel, M.
    Nalcaci, M.
    LEUKEMIA RESEARCH, 2019, 85 : S52 - S53
  • [25] Treatment of immune-mediated thrombotic thrombocytopenic purpura without plasma exchange
    Capecchi, Marco
    Gazzola, Giada
    Agosti, Pasquale
    De Leo, Pasqualina
    Mancini, Ilaria
    Ferrari, Barbara
    Giannotta, Juri Alessandro
    Artoni, Andrea
    Peyvandi, Flora
    HAEMATOLOGICA, 2024, 109 (06) : 2019 - 2023
  • [26] Immune-mediated thrombotic thrombocytopenic purpura: don't miss the boat
    Picod, Adrien
    Zafrani, Lara
    Azoulay, Elie
    INTENSIVE CARE MEDICINE, 2024, 50 (02) : 287 - 290
  • [27] Immune-mediated thrombotic thrombocytopenic purpura: don’t miss the boat
    Adrien Picod
    Lara Zafrani
    Elie Azoulay
    Intensive Care Medicine, 2024, 50 : 287 - 290
  • [28] Immune-mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure
    Joseph, Adrien
    Eloit, Martin
    Azoulay, Elie
    Kaplanski, Gilles
    Provot, Francois
    Presne, Claire
    Wynckel, Alain
    Grange, Steven
    Rondeau, Eric
    Pene, Frederic
    Delmas, Yahsou
    Lautrette, Alexandre
    Barbet, Christelle
    Mousson, Christiane
    Coindre, Jean-Philippe
    Perez, Pierre
    Jamme, Matthieu
    Augusto, Jean-Francois
    Poullin, Pascale
    Jacobs, Frederic
    El Karoui, Khalil
    Vigneau, Cecile
    Ulrich, Marc
    Kanouni, Tarik
    Le Quintrec, Moglie
    Hamidou, Mohamed
    Ville, Simon
    Charvet-Rumpler, Anne
    Ojeda-Uribe, Mario
    Godmer, Pascal
    Fremeaux-Bacchi, Veronique
    Veyradier, Agnes
    Halimi, Jean-Michel
    Coppo, Paul
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (04)
  • [29] Treatment of immune-mediated thrombotic thrombocytopenic purpura: A decisive turning point
    Poullin, P.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2021, 28 (04) : 380 - 385
  • [30] More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura
    Picod, Adrien
    Benhamou, Ygal
    Bouzid, Raida
    Veyradier, Agnes
    Coppo, Paul
    BLOOD ADVANCES, 2023, 7 (12) : 2678 - 2680